SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008822
Filing Date
2017-05-04
Accepted
2017-05-04 16:42:07
Documents
91
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q Q1 2017 bmrn-10q_20170331.htm 10-Q 3019349
2 EX-31.1 bmrn-ex311_7.htm EX-31.1 16297
3 EX-31.2 bmrn-ex312_8.htm EX-31.2 16365
4 EX-32.1 bmrn-ex321_6.htm EX-32.1 5748
  Complete submission text file 0001564590-17-008822.txt   12752074

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20170331.xml EX-101.INS 3695503
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20170331.xsd EX-101.SCH 60344
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20170331_cal.xml EX-101.CAL 70043
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20170331_def.xml EX-101.DEF 244843
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20170331_lab.xml EX-101.LAB 464676
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20170331_pre.xml EX-101.PRE 401841
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 17814701
SIC: 2834 Pharmaceutical Preparations